ConductScience.org, home

Paper33882157

Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir.

Ueda M and 4 others. Clin Pharmacol Ther, 2022. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir. Papers, record 33882157. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33882157

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Japan's Drug Regulation During the COVID-19 Pandemic: Lessons From a Case Study of Favipiravir.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
1.04
iCite
Revised in PubMed
2022-12-07
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ueda MMunetakahttps://orcid.org/0000-0002-9343-8380
2Tanimoto TTetsuya
3Murayama AAnju
4Ozaki AAkihiko
5Kami MMasahiro

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmidesMajor topic
Antiviral AgentsMajor topic
Drug ApprovalMajor topic
PyrazinesMajor topic
Adenosine Monophosphate
Alanine
COVID-19
Clinical Trials, Phase III as Topic
Dexamethasone
Double-Blind Method
Humans
Japan
COVID-19 Drug Treatment

Source PubMed

Download CSV of topics

References3

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132445440Remdesivir for the Treatment of Covid-19 - Final Report.N Engl J Med2020https://conductscience.org/library/papers/32445440PubMed
232678530Dexamethasone in Hospitalized Patients with Covid-19.N Engl J Med2021https://conductscience.org/library/papers/32678530PubMed
332870235Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.JAMA2020https://conductscience.org/library/papers/32870235PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42844389Towards broader-spectrum direct-acting antivirals against RNA viruses.Nat Rev Microbiol2026https://conductscience.org/library/papers/42844389PubMed
40103591Dysregulated glycerophospholipid metabolism in amygdala may mediate favipiravir-induced anxiety-like behaviors in mice.Front Pharmacol2025https://conductscience.org/library/papers/40103591PubMed
38402214Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID).Pneumonia (Nathan)2024https://conductscience.org/library/papers/38402214PubMed
37168925Impact of common comorbidities on antimicrobial consumption and mortality amongst critically ill COVID-19 patients: A retrospective two center study in Saudi Arabia.Clin Infect Pract2023https://conductscience.org/library/papers/37168925PubMed
37142688Therapeutics for COVID-19.Nat Microbiol2023https://conductscience.org/library/papers/37142688PubMed
36366550Antiviral Potential of Natural Resources against Influenza Virus Infections.Viruses2022https://conductscience.org/library/papers/36366550PubMed
35308532Favipiravir Effectiveness and Safety in Hospitalized Moderate-Severe COVID-19 Patients: Observational Prospective Multicenter Investigation in Saudi Arabia.Front Med (Lausanne)2022https://conductscience.org/library/papers/35308532PubMed
34391321An update of anti-viral treatment of COVID-19Turk J Med Sci2021https://conductscience.org/library/papers/34391321PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33882157

GET https://conductscience.org/api/papers/v1/33882157/authors